Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 8/2018

Content (10 Articles)

Colorectal Cancer: Why Does Side Matter?

  • Current Opinion

Claire Gallois, Simon Pernot, Aziz Zaanan, Julien Taieb

Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?

  • Leading Article

Stefan Weisshaar, Markus Zeitlinger

Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review

  • Leading Article

Loïc Raffray, Loïc Guillevin

Management of Embolic Stroke of Undetermined Source (ESUS)

  • Review Article

Tobias Geisler, Annerose Mengel, Ulf Ziemann, Sven Poli

Mirabegron: A Review in Overactive Bladder Syndrome

  • Adis Drug Evaluation

Emma D. Deeks

Tildrakizumab: First Global Approval

  • AdisInsight Report

Anthony Markham

Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

  • Open Access
  • Letter to the Editor

Antonio Pires, Kavitha Goyal, Andrew Greenspan

Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

  • Open Access
  • Letter to the Editor

Hillel P. Cohen, Andrew Blauvelt, Robert M. Rifkin, Silvio Danese, Sameer B. Gokhale, Gillian Woollett

Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

  • Open Access
  • Correction

Sheridan M. Hoy

Correction to: Ibalizumab: First Global Approval

  • Open Access
  • Correction

Anthony Markham

Jun 18
Issue: 9/2018
Jul 18
Issue: 10/2018

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images